Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Richard

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Drugs|January 10, 2006
Vascular effects of calcium channel antagonists: new evidenceSylvain Richard
Frontiers in Cell and Developmental Biology|October 21, 2015
Stimulating endogenous cardiac repairAmanda Finan, Sylvain Richard
Progress in Biophysics and Molecular Biology|July 26, 2005
From funny current to current physiomePeter Kohl, Sylvain Richard
Expert Opinion on Drug Safety|February 25, 2009
Prolongation in QT interval is not predictive of Ca2+-dependent arrhythmias: implications for drug safetyJean-Luc Pasquié, Sylvain Richard
Cardiovascular Research|September 15, 2004
Mutant cardiac ryanodine receptors and ventricular arrhythmias: is 'gain-of-function' obligatory?Ana Maria Gomez, Sylvain Richard
Medecine Sciences : M/S|April 15, 2008
[Ryanodine receptor and heart disease]Alain Lacampagne, Jérémy Fauconnier, Sylvain Richard
Cardiovascular Research|May 13, 2006
Unzipping RyR2 in adult cardiomyocytes: getting closer to mechanisms of inherited ventricular arrhythmias?Maria Fernandez-Velasco, Ana Maria Gomez, Sylvain Richard
The Journal of Biological Chemistry|July 29, 2004
Ca2+ controls functional expression of the cardiac K+ transient outward current via the calcineurin pathwayEmeline Perrier, Romain Perrier, Sylvain Richard, et al.
The Journal of Biological Chemistry|November 14, 2001
Permissive effect of voltage on mGlu 7 receptor subtype signaling in neuronsJulie Perroy, Sylvain Richard, Joel Nargeot, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible RepositioningSarah Rouhana, Anne Virsolvy, Nassim Fares, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Drugs|January 10, 2006
Vascular effects of calcium channel antagonists: new evidenceSylvain Richard
Frontiers in Cell and Developmental Biology|October 21, 2015
Stimulating endogenous cardiac repairAmanda Finan, Sylvain Richard
Progress in Biophysics and Molecular Biology|July 26, 2005
From funny current to current physiomePeter Kohl, Sylvain Richard
Expert Opinion on Drug Safety|February 25, 2009
Prolongation in QT interval is not predictive of Ca2+-dependent arrhythmias: implications for drug safetyJean-Luc Pasquié, Sylvain Richard
Cardiovascular Research|September 15, 2004
Mutant cardiac ryanodine receptors and ventricular arrhythmias: is 'gain-of-function' obligatory?Ana Maria Gomez, Sylvain Richard
Medecine Sciences : M/S|April 15, 2008
[Ryanodine receptor and heart disease]Alain Lacampagne, Jérémy Fauconnier, Sylvain Richard
Cardiovascular Research|May 13, 2006
Unzipping RyR2 in adult cardiomyocytes: getting closer to mechanisms of inherited ventricular arrhythmias?Maria Fernandez-Velasco, Ana Maria Gomez, Sylvain Richard
The Journal of Biological Chemistry|July 29, 2004
Ca2+ controls functional expression of the cardiac K+ transient outward current via the calcineurin pathwayEmeline Perrier, Romain Perrier, Sylvain Richard, et al.
The Journal of Biological Chemistry|November 14, 2001
Permissive effect of voltage on mGlu 7 receptor subtype signaling in neuronsJulie Perroy, Sylvain Richard, Joel Nargeot, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible RepositioningSarah Rouhana, Anne Virsolvy, Nassim Fares, et al.
Pageof 12